Related Experiment Video
Updated: Dec 29, 2025
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
Stem Cell Therapy for Acute Myocardial Infarctions: A Systematic Review
Joseph Rudman1, William H Frishman2
1From the Department of Internal Medicine, Zucker School of Medicine-Northwell Staten Island University.
Insights
Myocardial infarction causes permanent heart damage. Stem cell therapy offers a promising approach to regenerate cardiac tissue and improve heart function, with clinical trials showing its safety and potential.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Stem Cell Biology
Background:
- Myocardial infarction (MI) leads to irreversible cardiomyocyte loss and cardiac dysfunction.
- Current treatments reduce mortality but do not prevent heart failure progression.
- Regenerative approaches are needed to restore cardiac function post-MI.
Purpose of the Study:
- To review clinical trials using stem cells for myocardial regeneration.
- To discuss the potential of various stem cell lineages in cardiac repair.
- To identify future research directions in stem cell therapy for heart attack.
Main Methods:
- Systematic review of clinical trials involving stem cell transplantation post-MI.
- Analysis of different stem cell types (e.g., mesenchymal stem cells, induced pluripotent stem cells) and their efficacy.
- Evaluation of safety data from completed and ongoing trials.
Main Results:
- Clinical trials have established the safety of stem cell therapy in MI patients.
- Evidence suggests potential for stem cell-based regeneration of cardiac tissue.
- Variability exists in outcomes depending on cell type and delivery method.
Conclusions:
- Stem cell therapy is a safe and promising strategy for myocardial regeneration.
- Further research is required to optimize cell selection and therapeutic protocols.
- Stem cell-based approaches may offer a novel treatment to reverse heart failure after MI.
Abstract:
Each year 790,000 people in the United States suffer from a myocardial infarction. This results in the permanent loss of cardiomyocytes and an irreversible loss of cardiac function. Current therapies lower mortality rates, but do not address the core pathology, which opens a pathway to step-wise heart failure. Utilizing stem cells to regenerate the dead tissue is a potential method to reverse these devastating effects. Several clinical trials have already demonstrated the safety of stem cell therapy. In this review, we highlight clinical trials, which have utilized various stem cell lineages, and discuss areas for future research.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
01:28Acute Coronary Syndrome IV: Interprofessional Care